DTIL

7.4007.09%
JA

John Alexander Kelly

Chief Operating Officer

Mr. John Alexander Kelly, R.Ph., also known as Alex, served as Chief Corporate Affairs Officer at Precision BioSciences, Inc. since October 2020 until January 1, 2021 and had been its Interim Chief Financial Officer since January 1, 2021 until May 2021. He served as Chief Financial Officer at Precision BioSciences, Inc. since May 2021 until August 1, 2026 and served as its Principal Accounting Officer since September 15, 2023 until August 1, 2026 and is its Chief Operating Officer since August 1, 2026. He served as President of The Allergan Foundation. He had been the Chief Communications Officer and Executive Vice President at Allergan plc since April 20, 2015 until May 8, 2020. Mr. Kelly served as Chief Integration Officer and Senior Vice President at Actavis plc since July 1, 2014. He served as the Chief Communications & Investor Relations Officer of Forest Laboratories Inc. since December 2013 and as its Senior Vice President since October 25, 2013. Mr. Kelly served as Chief Communications Officer and Senior Vice President of Public Affairs and Investor Relations at Forest Laboratories Inc. since October 25, 2013 until December 2013. Mr. Kelly leads Forest's corporate communications and Investor Relations (IR) programs, including internal and external communications, media relations, corporate branding, product communications and public affairs. He has been Vice Chairman of the Board at California Life Sciences Association since May 9, 2019. Previously, Mr. Kelly was the Chair of the HealthCare Institute of New Jersey. He served as Vice President of Investor Relations at Bausch & Lomb Holdings Incorporated. Mr. Kelly served as Vice President of Investor Relations at Bausch & Lomb Incorporated since May 9, 2013. He joined Bausch & Lomb Inc. from Merck & Co., Inc., where he served as Vice President of Investor Relations and Senior Vice President of Investor Relations. Mr. Kelly served as Vice President of Investor Relations of Schering-Plough Corporation since June 2004 and served as its Group Vice President of Global Communications. He has experience in the pharmaceutical industry. While at Novartis, he was based in Switzerland and focused on building relationships with European Investors and Analysts. He served as Executive Director of Investor Relations of Novartis Corporation. He served as Senior Director of Investor Relations of Pharmacia Corporation. He has advanced to positions of increasing responsibility in Investor Relations and sales at Pharmacia Corporation, Pharmacia & Upjohn and The Upjohn Company. Mr. Kelly started his career as a pharmaceutical sales Representative. He has been a Director of California Life Sciences Association since August 02, 2016. He is a Registered Pharmacist. Mr. Kelly received a Bachelor of Science Degree in Pharmacy from Purdue University in Indiana.

Positions